BIB : Analysis & Opinions

  1. Trump Foreshadows a Bleak Outlook for Biotech

    January 18, 2017
    Biotech sector stocks surged after the election, but pulled back when Trump targeted drug companies.
  2. BIB vs. LABU: Comparing Leveraged Biotech ETFs

    May 4, 2016
    Discover a comparison between BIB and LABU, and learn about the characteristics and historical performance of these leveraged ...
  3. BIB: ProShares Ultra Nasdaq Biotechnology ETF

    December 22, 2015
    Find out information about the ProShares Ultra Nasdaq Biotechnology exchange-traded fund, and learn detailed analysis of ...
  4. Why These 7 Leveraged ETFs Are 2015's Best (ERY, BIB)

    September 10, 2015
    2015's top-performing leveraged ETFs come with significant risks. Are they right for you?
  5. Top 3 Biotech ETFs (XBI, IBB)

    August 14, 2015
    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term ...
  6. Are Bears About to Burst the Biotech Bubble? (IBB, BIB)

    July 2, 2015
    The recent biotech rally has richly rewarded many investors. So will the fortunes be soon swept away?
  7. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  8. Are These Your Best ETF, ETN Bets for 2015?

    May 5, 2015
    These 10 ETFs and ETNs have been on fire, but will investors who don't proceed with caution get burned?